ibio.orgiBIO | To promote, connect and engage the life sciences community

312-422-1111 ibioadmin@ibio.org About Introduction Leadership About Illinois Contact EDUCATE Overview STEMKits StellarGirls STEMFamilyCamp STEMGirls Camp STEMGirls Camp Fundraiser Advocacy Overview Advocacy Center Advocacy Toolkit News & Events News Events Daily Newsletter iCON Awards Member Resources Member Benefits Business Solutions CONNECT Partnering Member Committees Grant Opportunities Join iBIO COVID COVID-19 PPE Response Fund COVID-19 Resources Select Page iBIO Launches the iBIO STEM Kit Program to Support High-need, Low-income Students Learn More iBIO Named in ‘100 Associations That Will Save the World’ Learn More Building a more resilient and inclusive Life Sciences community Learn More Promoting, Connecting and Engaging the life sciences community to drive discovery, transform lives through groundbreaking research and grow the Illinois economy. Learn More Become a member of iBIO! Learn More Promoting, Connecting and Engaging the life sciences community to drive discovery, transform lives through groundbreaking research and grow the Illinois economy. Learn More Become a member of iBIO! Learn More iBIO is a life sciences industry association that represents the 85,000 life sciences employees at member companies, universities, service providers and venture firms. iBIO promotes the industry’s value to the public and policymakers; connects innovators to investment and talent; stimulates collaboration and fosters the next generation of innovators and entrepreneurs to transform patient lives through groundbreaking research and works to grow the Illinois economy. PROMOTE …the innovations, the policies and the people in the region CONNECT …research to development, talent to opportunities, entrepreneurs to resources ENGAGE …through leaning opportunities, community involvement, and collaboration MISSION To promote, connect and engage the life sciences community to drive discovery, transform lives through groundbreaking research and grow the Illinois economy. VISION To make Illinois and Chicago one of the world’s top life sciences centers. iBIO is the state trade association representing the life sciences industry in Illinois. Our membership ranges from global corporations to startup companies in the biopharma, medical device and nutrition industries. The Illinois life sciences industry is large, growing and recognized as a national leader. iBIO’s members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients lives and fostering a diverse STEM pipeline of scientists, entrepreneurs and innovators. Employees Economic Output (Billion) Girls have participated in EDUCATE Programming 2019 STATE OF THE INDUSTRY This 2019 iBIO State of the State report benchmarks the recent growth of the community, identifies key trends, and provides a road map for how we can continue to expand life sciences innovation in Illinois. CLICK HERE TO READ THE FULL REPORT Making Illinois One of the Top Life Sciences Centers PROMOTE – CONNECT – ENGAGE Join iBIO iBIO promotes the industry’s value to the public and policymakers; connects innovators to investment and talent; stimulates collaboration and fosters the next generation of innovators and entrepreneurs to transform patient lives through groundbreaking research and works to grow the Illinois economy. EDUCATE iBIO coordinates the industries engagement in STEM programs for girls grades 3-8 in underserved Illinois communities. Learn More COMMUNITY ENGAGEMENT iBIO connects & engages our members on key issues and areas of community development. Learn More ADVOCACY iBIO promotes the Illinois life sciences community and engages our members in advocacy at the federal, state and local levels. Learn More BUSINESS SOLUTIONS iBIO’s Business Solutions Program is part of the largest cost purchasing program for the life sciences industry, with more than $570 million in annual sales. Learn More Member Benefits Upcomming Events Current Month JOIN MCDERMOTT & EY AT THE 2021 J.P. MORGAN HEALTHCARE CONFERENCE 07 jan All Day 13 feb JOIN MCDERMOTT & EY AT THE 2021 J.P. MORGAN HEALTHCARE CONFERENCE Event Details You won’t want to miss four days of exclusive, virtual events that bring together industry leaders, emerging standouts, innovators and investors from across the industry landscape at the largest healthcare Event Details You won’t want to miss four days of exclusive, virtual events that bring together industry leaders, emerging standouts, innovators and investors from across the industry landscape at the largest healthcare investment symposium. Healthcare leaders will address comprehensive trends and implications faced in Digital Health, Life Sciences, Healthcare Private Equity (PE) and Hospitals and Health Systems (HHS). Develop an effective, long-term strategy through the post-pandemic period while forging deals and funding agreements to impact the industry’s future. EVENTS *Registration is complimentary DIGITAL HEALTH Thursday, January 7, 2021 12:00 – 2:00 pm EST Join top industry executives for a series of fireside chats on the evolving doctor-patient relationship and the digitized data and technology convergence with healthcare delivery and payment. Gain insight into 2021’s regulatory considerations affecting healthcare innovation and its solutions. Panelists: BJ Moore, Executive Vice President and Chief Information Officer, Providence St. Joseph Health Jodi Rosen, Senior Director, Innovation, Walgreens Boots Alliance Dr. Ali Parsa, Chief Executive Officer, Babylon Health LIFE SCIENCES INVESTMENT FORUM Monday, January 11, 2021 10:00 am – 1:00 pm EST Biopharma 10:00 – 11:00 am 2020 was a year like no other as the annual biopharma M&A total fell to the lowest level since EY began publishing its annual M&A Firepower report in 2013. In the first half of the year, the specter of COVID-19 deterred deals; as economies started to reopen, persistently high valuations were another reason many buyers remained on the fence. In the midst of such uncertainty, an innovation narrative emerged, with growing evidence of the power of new technologies, from antibody drug conjugates in oncology to RNA-based vaccines. These new innovations sparked many of 2020’s most notable deals and are sure to be important in the future. In this one hour panel discussion, we will discuss the current state of biopharma dealmaking and its implications for 2021 with M&A leaders from across the industry. Topics include: How current high valuations and liquidity play into deal considerations in a COVID and post-COVID world The continued importance of therapy area focus – and its impact on dealmaking, especially bolt-ons and partnering How strategic buyers and sellers can work with private equity in the current environment How M&A and partnering will be used to add capabilities required to deliver care in the home as virtual care becomes the norm Panelists: Stefan Oschmann, Chairman and CEO, Merck KGaA, Darmstadt, Germany John Young, Group President and Chief Business Officer, Pfizer Elizabeth Mily, EVP, Strategy and Business Development, Bristol Myers Squibb Moderator: Peter Behner, Global Health Sciences & Wellness Strategy and Transactions Leader, EY MedTech 11:00 am – 12:00 pm Well, 2020 was a wild ride. Due to the pandemic, medtech was right in the middle, supplying critical lifesaving technologies such as ventilators and early detection diagnostics and suffering losses as physicians and patients deferred less acute procedures. Medtech M&A for 2020 was light but the sector managed to remain active and 2H20 did produce a few large transactions. With global hospital utilizations continuing to improve month over month and (hopefully) more visibility into 2021 operating results, the medtech M&A market could be poised for a decent rebound and increase going into 2021. The EY/MWE Medtech Panel will focus on the M&A outloo...